Debt-to-equity of IO Biotech, Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IO Biotech, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • IO Biotech, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 158%, a 948% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IO Biotech, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 158% +143% +948% 30 Sep 2025
Q2 2025 66% +54% +453% 30 Jun 2025
Q1 2025 30% +19% +163% 31 Mar 2025
Q4 2024 20% +8.7% +78% 31 Dec 2024
Q3 2024 15% +4.8% +48% 30 Sep 2024
Q2 2024 12% +3% +33% 30 Jun 2024
Q1 2024 11% +3.8% +50% 31 Mar 2024
Q4 2023 11% +5% +82% 31 Dec 2023
Q3 2023 10% +5% +96% 30 Sep 2023
Q2 2023 9.1% -3.7% -29% 30 Jun 2023
Q1 2023 7.6% 31 Mar 2023
Q4 2022 6.2% 31 Dec 2022
Q3 2022 5.2% 30 Sep 2022
Q2 2022 13% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.